MyMD Pharmaceuticals Probability of Future Stock Price Finishing Over 1.82

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
MyMD Pharmaceuticals' future price is the expected price of MyMD Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of MyMD Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
  
Please specify MyMD Pharmaceuticals' target price for which you would like MyMD Pharmaceuticals odds to be computed.

MyMD Pharmaceuticals Target Price Odds to finish over 1.82

The tendency of MyMD Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.82 90 days 1.82 
about 75.89
Based on a normal probability distribution, the odds of MyMD Pharmaceuticals to move above the current price in 90 days from now is about 75.89 (This MyMD Pharmaceuticals probability density function shows the probability of MyMD Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days MyMD Pharmaceuticals has a beta of -0.64. This indicates as returns on the benchmark increase, returns on holding MyMD Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, MyMD Pharmaceuticals is likely to outperform the market. Additionally MyMD Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   MyMD Pharmaceuticals Price Density   
       Price  

Predictive Modules for MyMD Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MyMD Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1.821.821.82
Details
Intrinsic
Valuation
LowRealHigh
1.691.692.00
Details

MyMD Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. MyMD Pharmaceuticals is not an exception. The market had few large corrections towards the MyMD Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MyMD Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MyMD Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.72
β
Beta against Dow Jones-0.64
σ
Overall volatility
0.37
Ir
Information ratio -0.16

MyMD Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MyMD Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MyMD Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
MyMD Pharmaceuticals is now traded under the symbol TNFA. Please update your portfolios or report it if you believe this is an error. Report It!
MyMD Pharmaceuticals is not yet fully synchronised with the market data
MyMD Pharmaceuticals may become a speculative penny stock
MyMD Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0.
MyMD Pharmaceuticals currently holds about 5.62 M in cash with (12.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.

MyMD Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MyMD Stock often depends not only on the future outlook of the current and potential MyMD Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MyMD Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.5 M
Cash And Short Term Investments4.9 M

MyMD Pharmaceuticals Technical Analysis

MyMD Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. MyMD Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MyMD Pharmaceuticals. In general, you should focus on analyzing MyMD Stock price patterns and their correlations with different microeconomic environments and drivers.

MyMD Pharmaceuticals Predictive Forecast Models

MyMD Pharmaceuticals' time-series forecasting models is one of many MyMD Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MyMD Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about MyMD Pharmaceuticals

Checking the ongoing alerts about MyMD Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MyMD Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
MyMD Pharmaceuticals is now traded under the symbol TNFA. Please update your portfolios or report it if you believe this is an error. Report It!
MyMD Pharmaceuticals is not yet fully synchronised with the market data
MyMD Pharmaceuticals may become a speculative penny stock
MyMD Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0.
MyMD Pharmaceuticals currently holds about 5.62 M in cash with (12.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios